Literature DB >> 11956079

Associations between hOGG1 sequence variants and prostate cancer susceptibility.

Jianfeng Xu1, Siqun L Zheng, Aubrey Turner, Sarah D Isaacs, Kathy E Wiley, Gregory A Hawkins, Bao-li Chang, Eugene R Bleecker, Patrick C Walsh, Deborah A Meyers, William B Isaacs.   

Abstract

8-Hydroxyguanine is a mutagenic base lesion produced by reactive oxygen species. The hOGG1 gene encodes a DNA glycosylase/AP lyase that can suppress the mutagenic effects of 8-hydroxyguanine by catalyzing its removal from oxidized DNA. A population-based (245 cases and 222 controls) and family-based (159 hereditary prostate cancer families) association study was performed to test the hypothesis that sequence variants of hOGG1 increase susceptibility to prostate cancer. We found that the genotype frequency of two sequence variants (11657A/G and Ser326Cys) was significantly different between cases and controls. The association with 11657A/G is confirmed and strengthened by our family-based association study. These results suggest that sequence variants in this gene are associated with prostate cancer risk, presumably through defective DNA repair function of hOGG1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956079

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Biomarkers of Psychological Stress in Health Disparities Research.

Authors:  Zora Djuric; Chloe E Bird; Alice Furumoto-Dawson; Garth H Rauscher; Mack T Ruffin; Raymond P Stowe; Katherine L Tucker; Christopher M Masi
Journal:  Open Biomark J       Date:  2008-01-01

2.  Genetic association between hOGG1 C8069G polymorphism and colorectal cancer risk.

Authors:  Xiaoge Sun; Hao Yang; Yu Lin; Jianguo Zhao; Yinna Bao; Xiulan Liu; Zhen Qi; Shaojun Wang; Congxiu Huang; Zhilong Yu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 3.  Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis.

Authors:  Benjamin A Rybicki; Nora L Nock; Adnan T Savera; Deliang Tang; Andrew Rundle
Journal:  Cancer Lett       Date:  2005-09-09       Impact factor: 8.679

4.  DNA damage phenotype and prostate cancer risk.

Authors:  O Kosti; L Goldman; D T Saha; R A Orden; A J Pollock; H L Madej; A W Hsing; L W Chu; J H Lynch; R Goldman
Journal:  Mutat Res       Date:  2010-11-21       Impact factor: 2.433

Review 5.  Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk.

Authors:  Jong Y Park; Yifan Huang; Thomas A Sellers
Journal:  Methods Mol Biol       Date:  2009

6.  Analysis of DNA Repair Genes Polymorphisms in Breast Cancer.

Authors:  Hanna Romanowicz; Łukasz Pyziak; Filip Jabłoński; Magdalena Bryś; Ewa Forma; Beata Smolarz
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

7.  Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study.

Authors:  Ilir Agalliu; Erika M Kwon; Claudia A Salinas; Joseph S Koopmeiners; Elaine A Ostrander; Janet L Stanford
Journal:  Cancer Causes Control       Date:  2009-11-10       Impact factor: 2.506

Review 8.  The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer.

Authors:  Huy Q Ta; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2014-08-05       Impact factor: 5.678

9.  Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China.

Authors:  Tao Peng; Han-Ming Shen; Zhi-Ming Liu; Lu-Nan Yan; Min-Hao Peng; Le-Qun Li; Ren-Xiang Liang; Zong-Liang Wei; Barry Halliwell; Choon Nam Ong
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

10.  Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma.

Authors:  Monika Forsbring; Erik S Vik; Bjørn Dalhus; Tom H Karlsen; Annika Bergquist; Erik Schrumpf; Magnar Bjørås; Kirsten M Boberg; Ingrun Alseth
Journal:  Carcinogenesis       Date:  2009-05-14       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.